A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000

References

• KassebaumNJJasrasariaRNaghaviMA systematic analysis of global anemia burden from 1990 to 2010Blood201412361562424297872
   PubMed Web of Science ®Google Scholar
• CamaschellaCIron-deficiency anemiaN Engl J Med2015372191832184325946282
   PubMed Web of Science ®Google Scholar
• BMJ Best PracticeIron deficiency anaemia. Epidemiology Available from: http://bestpractice.bmj.com/best-practice/monograph/94/basics/epidemiology.htmlAccessed January 17, 2017
   Google Scholar
• LookerACDallmanPRCarrollMDGunterEWJohnsonCLPrevalence of iron deficiency in the United StatesJAMA1997277129739769091669
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceClinical Knowledge Summaries. Anaemia – Iron DeficiencyLondon2013 Available from: https://cks.nice.org.uk/anaemia-iron-deficiencyAccessed February 15, 2017
   Google Scholar
• WHOHaemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity Vitamin and Mineral Nutrition Information SystemGenevaWorld Health Organization2011 Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdfAccessed March 30, 2017
   Google Scholar
• GuyattGHOxmanADAliMWillanAMcIlroyWPattersonCLaboratory diagnosis of iron-deficiency anemia: an overviewJ Gen Intern Med1992721451531487761
   PubMed Web of Science ®Google Scholar
• Johnson-WimbleyTDGrahamDYDiagnosis and management of iron deficiency anemia in the 21st centuryTherap Adv Gastroenterol201143177184
   PubMedGoogle Scholar
• NHS Blood and TransplantNational Comparative Audit of Blood Transfusion Available from: http://hospital.blood.co.uk/audits/national-comparative-audit/Accessed March 31, 2017
   Google Scholar
• DignassAUGascheCBettenworthDEuropean Crohn’s and Colitis Organisation [ECCO]European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseasesJ Crohns Colitis20159321122225518052
   PubMed Web of Science ®Google Scholar
• GoddardAFJamesMWMcIntyreASScottBBBritish Society of GastroenterologyGuidelines for the management of iron deficiency anaemiaGut201160101309131621561874
   PubMed Web of Science ®Google Scholar
• BayraktarUDBayraktarSTreatment of iron deficiency anemia associated with gastrointestinal tract diseasesWorld J Gastroenterol201016222720272520533591
   PubMed Web of Science ®Google Scholar
• CançadoRDMuñozMIntravenous iron therapy: how far have we come?Rev Bras Hematol Hemoter201133646146923049364
   PubMedGoogle Scholar
• RichardsTClevengerBKeidanJPREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trialTrials20151625426041028
   PubMed Web of Science ®Google Scholar
• BhandariSUpdate of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practiceTher Clin Risk Manag2011750150922241947
   PubMed Web of Science ®Google Scholar
• KochTAMyersJGoodnoughLTIntravenous iron therapy in patients with iron deficiency anemia: dosing considerationsAnemia2015201576357626257955
   PubMed Web of Science ®Google Scholar
• KulniggSStoinovSSimanenkovVA novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trialAm J Gastroenterol200810351182119218371137
   PubMed Web of Science ®Google Scholar
• electronic Medicines Compendium (eMC)Ferinject (ferric carboxymaltose) – summary of product characteristics Available from: https://www.medicines.org.uk/emc/medicine/24167Accessed March 2, 2017
   Google Scholar
• electronic Medicines Compendium (eMC)Venofer (iron sucrose) – summary of product characteristics Available from: https://www.medicines.org.uk/emc/medicine/24168Accessed March 2, 2017
   Google Scholar
• The Health and Social Care Information CentreHospital Episode Statistics for England: Healthcare Resource Groups – HRG version 4 Available from: http://content.digital.nhs.uk/hesAccessed March 2, 2017
   Google Scholar
• SullivanSDMauskopfJAAugustovskiFBudget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task ForceValue Health201417151424438712
   PubMed Web of Science ®Google Scholar
• PollockRFKappelgaardAMSeitzLAn analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devicesExpert Opin Drug Deliv201512335336025614081
   PubMed Web of Science ®Google Scholar
• Office for National StatisticsAnnual Small Area Population Estimates: Mid-2014 and Mid-2013 Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualsmallareapopulationestimates/mid2014andmid2013Accessed March 31, 2017
   Google Scholar
• AMAG Pharmaceuticals IncAMAG Analyst Day 2016. SEC 8-K Filing 2016. Exhibit 99.1 Available from: https://www.sec.gov/Archives/edgar/data/792977/000110465916124649/a16-12443_1ex99d1.htmAccessed February 22, 2017
   Google Scholar
• FrigstadSORannemTHellstromPMHammarlundPBonderupOA Scandinavian prospective observational study of iron isomaltoside 1000 treatment: clinical practice and outcomes in iron deficiency anaemia in patients with IBDPoster P481 presented at: 10th Congress of the European Crohn’s and Colitis Organisation (ECCO)February 8–21, 2015Barcelona, Spain
   Google Scholar
• FrigstadSOHammarlundPBonderupOAnaemia and iron deficiency in gastroenterology: a Scandinavian prospective, observational study of iron isomaltoside in clinical practiceAbstract and poster P533 presented at: The 12th Congress of the European Crohn’s and Colitis Organisation (ECCO)February 15–18 2017Barcelona, Spain
   Google Scholar
• EvstatievRMarteauPIqbalTFERGI Study GroupFERGI-cor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel diseaseGastroenterology20111413846-853e1221699794
   PubMed Web of Science ®Google Scholar
• CalvetXRuízMÀDosalACost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiencyPLOS ONE201279e4560423029129
   PubMed Web of Science ®Google Scholar
• BhandariSA hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000Ther Clin Risk Manag201171031321479141
   PubMed Web of Science ®Google Scholar
• BrockEBraunhoferPTroxlerJSchneiderHBudget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life dataEur J Health Econ201415990791624081613
   PubMed Web of Science ®Google Scholar
• CalvetXGenéERuízMÀCost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemiaTechnol Health Care201624111112026409561
   PubMed Web of Science ®Google Scholar
• GozzardDWhen is high-dose intravenous iron repletion needed? Assessing new treatment optionsDrug Des Devel Ther201155160
   PubMed Web of Science ®Google Scholar
• electronic Medicines Compendium (eMC)CosmoFer (Iron(III)-hydroxide dextran complex) – summary of product characteristics Available from: https://www.medicines.org.uk/emc/medicine/14139Accessed March 2, 2017
   Google Scholar